Search research articles
Contact Us
Filters
Showing results (31-40 of 53) with videos related to
Page
of 6
Sort By:
Cancer
|
May 4, 2000
Invasive carcinoma in clinically suspicious breast masses diagnosed as adenocarcinoma by fine-needle aspiration
D C Chhieng, G Fernandez, J F Cangiarella, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 23, 2013
Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus Statement
H A Azim, S Michiels, F Zagouri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 26, 2008
Modulation of ER phosphorylation on serine 118 by endocrine therapy: a new surrogate marker for efficacy
M Zoubir, M C Mathieu, C Mazouni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 2, 2014
Residual proliferative cancer burden to predict long-term outcome following neoadjuvant chemotherapy
A Sheri, I E Smith, S R Johnston, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2001
Paclitaxel-induced apoptosis and mitotic arrest assessed by serial fine-needle aspiration: implications for early prediction of breast cancer response to neoadjuvant treatment
W F Symmans, M D Volm, R L Shapiro, et al.
British Journal of Cancer
|
February 21, 2012
A network-based, integrative study to identify core biological pathways that drive breast cancer clinical subtypes
B Dutta, L Pusztai, Y Qi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 1, 2008
Hormone receptor status and pathologic response of HER2-positive breast cancer treated with neoadjuvant chemotherapy and trastuzumab
F Peintinger, A U Buzdar, H M Kuerer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 15, 2009
Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer
C Liedtke, K Broglio, S Moulder, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 13, 2007
Inclusion of taxanes, particularly weekly paclitaxel, in preoperative chemotherapy improves pathologic complete response rate in estrogen receptor-positive breast cancers
C Mazouni, S-W Kau, D Frye, et al.
ESMO Open
|
February 11, 2026
Circulating tumor DNA in neoadjuvant endocrine therapy for early breast cancer
A Grinshpun, D Dustin, M Cai, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 53) with videos related to
Sort By:
Page
of 6
Cancer
|
May 4, 2000
Invasive carcinoma in clinically suspicious breast masses diagnosed as adenocarcinoma by fine-needle aspiration
D C Chhieng, G Fernandez, J F Cangiarella, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 23, 2013
Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus Statement
H A Azim, S Michiels, F Zagouri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 26, 2008
Modulation of ER phosphorylation on serine 118 by endocrine therapy: a new surrogate marker for efficacy
M Zoubir, M C Mathieu, C Mazouni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 2, 2014
Residual proliferative cancer burden to predict long-term outcome following neoadjuvant chemotherapy
A Sheri, I E Smith, S R Johnston, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2001
Paclitaxel-induced apoptosis and mitotic arrest assessed by serial fine-needle aspiration: implications for early prediction of breast cancer response to neoadjuvant treatment
W F Symmans, M D Volm, R L Shapiro, et al.
British Journal of Cancer
|
February 21, 2012
A network-based, integrative study to identify core biological pathways that drive breast cancer clinical subtypes
B Dutta, L Pusztai, Y Qi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 1, 2008
Hormone receptor status and pathologic response of HER2-positive breast cancer treated with neoadjuvant chemotherapy and trastuzumab
F Peintinger, A U Buzdar, H M Kuerer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 15, 2009
Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer
C Liedtke, K Broglio, S Moulder, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 13, 2007
Inclusion of taxanes, particularly weekly paclitaxel, in preoperative chemotherapy improves pathologic complete response rate in estrogen receptor-positive breast cancers
C Mazouni, S-W Kau, D Frye, et al.
ESMO Open
|
February 11, 2026
Circulating tumor DNA in neoadjuvant endocrine therapy for early breast cancer
A Grinshpun, D Dustin, M Cai, et al.
Page
of 6